Department of Surgery, 114438Charleston Area Medical Center, Charleston, WV, USA.
Charleston Area Medical Center Health Education and Research Institute, Charleston, WV, USA.
Vascular. 2023 Feb;31(1):72-82. doi: 10.1177/17085381211059660. Epub 2021 Dec 10.
The aim of this study was to determine the acute impact of baseline serum creatinine, estimated glomerular filtration rate (eGFR), and contrast medium volume (CMV) on the incidence of reduced renal function (RRF) after endovascular abdominal aortic aneurysm repair (EVAR). We aimed to determine if the CMV/eGFR ratio was a predictor of RRF.
This study is a retrospective review of EVAR patients in the Society for Vascular Surgery/Vascular Quality Initiative (SVS/VQI) from January 2015 to August 2020. Reduced renal function was defined as > 0.3 mg/dl (26.5 μmol/L), 50% increase from baseline, and temporary or permanent dialysis. Receiver operator characteristic (ROC) curve analyses were conducted for serum creatinine, eGFR, contrast volume, fluid volume, and CMV/eGFR ratio. Two data sets (training and test) were developed followed by multivariate analyses.
SVS/VQI data for EVAR contained 38,701 records, of which 30,539 were divided into training ( = 18,283; 60%) and test ( = 12,256; 40%) data sets. RRF rate for the training set was 3.6% ( = 667) and 3.4% ( = 420) for the test data. RRF patients included more females (29.4 vs 19.0%, < 0.001), were older in age (75.6 + 8.4 vs 73.3 + 8.7 years), had more congestive heart failure (22.3 vs 12.2%, < 0.001), and more COPD (42.0 vs 34.2%, < 0.001). An ROC analysis revealed that eGRF, creatinine, contrast, intravenous fluid, and contrast medium volume (CMV)/eGFR ratio were all significantly ( < 0.05) correlated with RRF. The eGFR and CMV/eGFR ratio had the largest area under the curve, (0.26) and (0.65), respectively, while fluid had the lowest (0.54). Negative predictive values were 93.7 (CMV/eGFR), 93.9 (creatinine), 94.2 (eGFR), 92.8 (contrast), and 92.6 (intravenous fluid). Multivariate analysis of the training data set resulted in the CMV/eGFR ratio as an independent predictor of RRF (odds ratio, OR: 1.9 with 95% CI: 1.6, 2.2, < 0.015). For the test data, the CMV/eGFR ratio was an independent predictor of RRF (OR: 1.8, CI: 1.4 to 2.2, < 0.001) as well as several other variables.
RRF after EVAR is a dreaded and potentially devastating complication. Baseline serum creatinine, eGFR, contrast medium volume, and the ratio (CMV/eGFR) were all significantly associated with RRF. The optimal cut-off value for the CMV/eGFR ratio, ≤ 2, provides an easy-to-use equation to provide a suggested contrast target based on initial renal function with caution applied for high-risk patients.
本研究旨在确定基线血清肌酐、估算肾小球滤过率(eGFR)和对比剂体积(CMV)对血管内腹主动脉瘤修复(EVAR)后肾功能下降(RRF)发生率的急性影响。我们旨在确定 CMV/eGFR 比值是否是 RRF 的预测因子。
这是一项对 2015 年 1 月至 2020 年 8 月期间血管外科学会/血管质量倡议(SVS/VQI)的 EVAR 患者进行的回顾性研究。RRF 定义为 > 0.3mg/dl(26.5μmol/L)、基线值增加 50%,以及临时或永久性透析。进行了血清肌酐、eGFR、对比剂体积、液体体积和 CMV/eGFR 比值的接收器操作特征(ROC)曲线分析。开发了两个数据集(训练和测试),然后进行了多变量分析。
SVS/VQI 的 EVAR 数据包含 38701 条记录,其中 30539 条记录分为训练集(=18283;60%)和测试集(=12256;40%)。训练集的 RRF 发生率为 3.6%(=667),测试集为 3.4%(=420)。RRF 患者中女性比例更高(29.4% vs 19.0%,<0.001),年龄更大(75.6+8.4 岁 vs 73.3+8.7 岁),充血性心力衰竭更多(22.3% vs 12.2%,<0.001),COPD 更多(42.0% vs 34.2%,<0.001)。ROC 分析显示,eGFR、肌酐、对比剂、静脉液体和 CMV/eGFR 比值均与 RRF 显著相关(<0.05)。eGFR 和 CMV/eGFR 比值的曲线下面积最大,分别为 0.26 和 0.65,而液体的曲线下面积最低,为 0.54。阴性预测值分别为 93.7%(CMV/eGFR)、93.9%(肌酐)、94.2%(eGFR)、92.8%(对比剂)和 92.6%(静脉液体)。训练数据集的多变量分析结果显示,CMV/eGFR 比值是 RRF 的独立预测因子(比值比,OR:1.9,95%置信区间:1.6,2.2,<0.015)。对于测试数据,CMV/eGFR 比值是 RRF 的独立预测因子(OR:1.8,CI:1.4 至 2.2,<0.001),以及其他几个变量。
EVAR 后 RRF 是一种可怕且潜在破坏性的并发症。基线血清肌酐、eGFR、对比剂体积和比值(CMV/eGFR)均与 RRF 显著相关。CMV/eGFR 比值的最佳截断值为≤2,提供了一种易于使用的公式,可以根据初始肾功能提供建议的对比剂目标,但对于高危患者应谨慎使用。